Study shows that most HPM fellows can discuss medical cannabis but feel insufficiently informed to make clinical recommendations, highlighting education gaps.

A study published in the Journal of Pain and Symptom Management surveyed Hospice and Palliative Medicine (HPM) fellows about their training, discussions, and perceptions of medical cannabis. The results showed that while the majority of fellows had received formal training and discussed medical cannabis with patients, few fellows (less than one-fifth) felt sufficiently informed to make clinical recommendations. The study highlights a need for improved training and more high-quality evidence on the effectiveness and safety of medical cannabis in palliative care.

Read more

Get the latest updates in your inbox!